SK286178B6 - Farmaceutická kompozícia obsahujúca makrolid a kyselinu, spôsob stabilizácie makrolidu proti degradácii a použitie kyseliny na jeho stabilizáciu - Google Patents

Farmaceutická kompozícia obsahujúca makrolid a kyselinu, spôsob stabilizácie makrolidu proti degradácii a použitie kyseliny na jeho stabilizáciu Download PDF

Info

Publication number
SK286178B6
SK286178B6 SK5048-2005A SK50482005A SK286178B6 SK 286178 B6 SK286178 B6 SK 286178B6 SK 50482005 A SK50482005 A SK 50482005A SK 286178 B6 SK286178 B6 SK 286178B6
Authority
SK
Slovakia
Prior art keywords
acid
macrolide
composition
compositions
examples
Prior art date
Application number
SK5048-2005A
Other languages
English (en)
Slovak (sk)
Inventor
Sylvain Cottens
Barbara Haeberlin
Richard Sedrani
Jacky Vonderscher
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421613A external-priority patent/GB9421613D0/en
Priority claimed from GB9422084A external-priority patent/GB9422084D0/en
Priority claimed from GBGB9425353.1A external-priority patent/GB9425353D0/en
Priority claimed from GBGB9517133.6A external-priority patent/GB9517133D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK286178B6 publication Critical patent/SK286178B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
  • Colloid Chemistry (AREA)
SK5048-2005A 1994-10-26 1995-10-25 Farmaceutická kompozícia obsahujúca makrolid a kyselinu, spôsob stabilizácie makrolidu proti degradácii a použitie kyseliny na jeho stabilizáciu SK286178B6 (sk)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9421613A GB9421613D0 (en) 1994-10-26 1994-10-26 Organic compounds
GB9422084A GB9422084D0 (en) 1994-11-02 1994-11-02 Organic compounds
GBGB9425353.1A GB9425353D0 (en) 1994-12-15 1994-12-15 Organic compounds
GBGB9517133.6A GB9517133D0 (en) 1995-08-22 1995-08-22 Pharmaceutical compositions
PCT/EP1995/004187 WO1996013273A1 (en) 1994-10-26 1995-10-25 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SK286178B6 true SK286178B6 (sk) 2008-04-07

Family

ID=27451224

Family Applications (2)

Application Number Title Priority Date Filing Date
SK521-97A SK285809B6 (sk) 1994-10-26 1995-10-25 Mikroemulzný prekoncentrát cyklosporínu alebo makrolidu
SK5048-2005A SK286178B6 (sk) 1994-10-26 1995-10-25 Farmaceutická kompozícia obsahujúca makrolid a kyselinu, spôsob stabilizácie makrolidu proti degradácii a použitie kyseliny na jeho stabilizáciu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SK521-97A SK285809B6 (sk) 1994-10-26 1995-10-25 Mikroemulzný prekoncentrát cyklosporínu alebo makrolidu

Country Status (25)

Country Link
EP (2) EP2039358A1 (de)
JP (3) JPH10509699A (de)
KR (2) KR100541198B1 (de)
CN (3) CN1124157C (de)
AT (1) ATE411800T1 (de)
AU (1) AU714360B2 (de)
BR (1) BR9509496A (de)
CA (1) CA2200967C (de)
CY (1) CY2210B1 (de)
CZ (1) CZ289838B6 (de)
DE (2) DE19581805T1 (de)
ES (1) ES2316150T3 (de)
FI (1) FI119497B (de)
HU (1) HU225535B1 (de)
IL (3) IL115742A (de)
MY (1) MY129435A (de)
NO (2) NO323078B1 (de)
NZ (1) NZ295655A (de)
PE (1) PE52896A1 (de)
PL (1) PL184368B1 (de)
PT (1) PT787011E (de)
SK (2) SK285809B6 (de)
TR (2) TR199500299A2 (de)
TW (1) TW308544B (de)
WO (1) WO1996013273A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
NZ280689A (en) * 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
CN1259053A (zh) * 1997-04-11 2000-07-05 藤泽药品工业株式会社 药物组合物
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
IN188719B (de) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
ATE497384T1 (de) 1997-12-10 2011-02-15 Cyclosporine Therapeutics Ltd Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
GB2380673B (en) * 1998-03-06 2003-05-28 Novartis Ag Emulsion preconcentrates containing cyclosporin or a macrolide
EP1075252A2 (de) * 1998-05-07 2001-02-14 ELAN CORPORATION, Plc Mikroemulsion frei von lösungsmittel und co-lösungsmittel und emulsionvorkonzentrat als wirkstoff freisetzungssytemen
TWI241915B (en) * 1998-05-11 2005-10-21 Ciba Sc Holding Ag A method of preparing a pharmaceutical end formulation using a nanodispersion
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
CN1151782C (zh) * 1999-01-28 2004-06-02 迪内希·尚蒂拉尔·帕特尔 一种具有哺乳动物麻醉的诱导和保持以及镇静用途的药用注射液
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
EP1980263A1 (de) 1999-05-10 2008-10-15 Novartis AG Kombinationen von immunsuppressiven Mitteln zur Behandlung bzw. Prävention von Transplantatabstoßungen
GB9912476D0 (en) 1999-05-28 1999-07-28 Novartis Ag Organic compounds
DE19925001A1 (de) * 1999-05-31 2000-12-07 Pharma Concepts Gmbh & Co Kg Flüssiges Konzentrat
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
CN1173695C (zh) * 1999-06-14 2004-11-03 科斯默股份公司 控制释放与掩蔽味道的口服药物组合物
KR100342942B1 (ko) * 1999-07-05 2002-07-02 민경윤 카르두스 마리아누스 추출물 또는 이로부터 정제된 실리빈을함유하는 경구용 마이크로에멀젼 조성물
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US7919113B2 (en) 1999-12-30 2011-04-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dispersible concentrate lipospheres for delivery of active agents
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US7056530B1 (en) * 2000-09-18 2006-06-06 Rpg Life Sciences Ltd. Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
JP2002193790A (ja) * 2000-12-27 2002-07-10 Lion Corp 水難溶性薬剤含有水中油型エマルジョン及びその製造方法
NZ527692A (en) 2001-02-19 2005-05-27 Novartis Ag Cancer treatment
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
CN100346785C (zh) * 2001-10-25 2007-11-07 迪内希尚蒂拉尔·帕特尔 选择性环氧化酶ⅱ抑制剂的新型制剂
SI1553940T1 (sl) * 2002-07-30 2008-08-31 Wyeth Corp Parenteralne farmacevtske oblike, ki vsebujejo rapamicin-hidroksiester
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
IL159729A0 (en) * 2004-01-06 2004-06-20 Doron I Friedman Non-aqueous composition for oral delivery of insoluble bioactive agents
CN101185638B (zh) * 2004-10-09 2011-04-06 山西中医学院 一种微乳制剂及其制备方法
CN100381175C (zh) * 2004-10-09 2008-04-16 山西中医学院 一种微乳制剂及其制备方法
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
CN1872058B (zh) * 2005-05-31 2011-03-30 华北制药集团新药研究开发有限责任公司 一种含大环内酯类化合物的药物组合物
ES2481671T3 (es) 2005-11-21 2014-07-31 Novartis Ag Inhibidores de mTOR en el tratamiento de tumores endocrinos
US7883855B2 (en) 2006-07-21 2011-02-08 Abbott Laboratories Immunosuppressant drug extraction reagent for immunoassays
CN1919194A (zh) * 2006-08-17 2007-02-28 刘瑜玲 西罗莫司的液体组合物
US7914999B2 (en) 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
ES2405364T3 (es) 2006-12-29 2013-05-30 Abbott Laboratories Ensayo diagnóstico para la detección de una molécula o fármaco en sangre entera
CA2673296C (en) 2006-12-29 2012-10-16 Abbott Laboratories Improved assay for immunosuppressant drugs
JP5319549B2 (ja) 2006-12-29 2013-10-16 アボット・ラボラトリーズ 溶液内捕捉イムノアッセイで使用する非変性細胞溶解試薬
WO2011024168A2 (en) 2009-08-26 2011-03-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd Sustained release delivery systems for the prevention and treatment of head and neck cancers
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
SG10201706208SA (en) 2012-03-23 2017-08-30 Univ Queensland Immunomodulatory Agent and Uses Therefor
WO2014184734A1 (en) 2013-05-14 2014-11-20 Novartis Ag Markers associated with mtor inhibition
WO2015044854A1 (en) 2013-09-24 2015-04-02 Novartis Ag Markers associated with mtor inhibition
CN103933546A (zh) * 2014-03-27 2014-07-23 北京科技大学 雷帕霉素与环孢素a纳米口服微乳液制备方法
JP7459458B2 (ja) * 2018-06-28 2024-04-02 ライオン株式会社 内服組成物及びその製造方法
WO2023139907A1 (ja) * 2022-01-24 2023-07-27 株式会社Moresco 防腐効果を付与したナノエマルジョン

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
US3244592A (en) 1962-06-09 1966-04-05 Arai Tadashi Ascomycin and process for its production
GB1380741A (en) * 1971-02-05 1975-01-15 Squibb & Sons Inc Antibiotic compositions and their preparation
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
ZA737247B (en) 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
JPS59104326A (ja) * 1982-12-04 1984-06-16 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法
JPS60163823A (ja) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd 経口投与製剤
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
EP0427680B1 (de) 1989-11-09 1995-08-23 Sandoz Ltd. Heteroatome enthaltende tricyclische Verbindungen
MY110418A (en) 1990-07-02 1998-05-30 Novartis Ag Heteroatoms-containing tricyclic compounds.
PT98990A (pt) 1990-09-19 1992-08-31 American Home Prod Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
US5120842A (en) 1991-04-01 1992-06-09 American Home Products Corporation Silyl ethers of rapamycin
US5100883A (en) 1991-04-08 1992-03-31 American Home Products Corporation Fluorinated esters of rapamycin
US5118678A (en) 1991-04-17 1992-06-02 American Home Products Corporation Carbamates of rapamycin
US5118677A (en) 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
US5151413A (en) 1991-11-06 1992-09-29 American Home Products Corporation Rapamycin acetals as immunosuppressant and antifungal agents
GB9125660D0 (en) 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compound
HUT66531A (en) 1992-05-07 1994-12-28 Sandoz Ag Heteroatoms-containing tricyclic compounds, pharmaceutical prepns contg. them and process for producing them
DE9208647U1 (de) 1992-06-27 1992-09-24 Rademacher, Antje, 4980 Buende, De
ZA935112B (en) 1992-07-17 1994-02-08 Smithkline Beecham Corp Rapamycin derivatives
US5234140A (en) 1992-07-28 1993-08-10 S. C. Johnson & Son, Inc. Re-useable aerosol container
US5256790A (en) 1992-08-13 1993-10-26 American Home Products Corporation 27-hydroxyrapamycin and derivatives thereof
CZ278863B6 (en) 1992-09-07 1994-07-13 Galena Medicinal preparations with n-methylated cyclic undecapeptides
EP0589843B1 (de) * 1992-09-25 2001-11-28 Novartis AG Cyclosporin enthaltende pharmazeutische Zusammensetzungen
GB9221220D0 (en) 1992-10-09 1992-11-25 Sandoz Ag Organic componds
FR2697040B1 (fr) 1992-10-21 1994-12-30 Ind Entreprise Elément de protection contre le bruit et son utilisation.
US5258389A (en) 1992-11-09 1993-11-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DK1033128T4 (da) * 1993-09-28 2012-03-19 Scherer Gmbh R P Blød gelatinekapselfremstilling
AU688782B2 (en) * 1993-09-30 1998-03-19 Wyeth Rapamycin formulations for oral administration
CA2175215C (en) 1993-11-19 2008-06-03 Yat Sun Or Semisynthetic analogs of rapamycin (macrolides) being immunomodulators

Also Published As

Publication number Publication date
EP2039358A1 (de) 2009-03-25
HU225535B1 (en) 2007-02-28
CZ289838B6 (cs) 2002-04-17
DE19581805T1 (de) 1997-10-16
NO323063B1 (no) 2006-12-27
CZ123197A3 (en) 1997-07-16
MX9702701A (es) 1997-10-31
SK285809B6 (sk) 2007-08-02
EP0787011A1 (de) 1997-08-06
AU3924895A (en) 1996-05-23
EP0787011B1 (de) 2008-10-22
CN1679938A (zh) 2005-10-12
BR9509496A (pt) 1997-09-30
CY2210B1 (en) 2002-11-08
HUT76858A (en) 1997-12-29
NO971898D0 (no) 1997-04-24
WO1996013273A1 (en) 1996-05-09
AU714360B2 (en) 1999-12-23
JPH10509699A (ja) 1998-09-22
SK52197A3 (en) 1997-09-10
JP2005247870A (ja) 2005-09-15
CN1404833A (zh) 2003-03-26
PL319691A1 (en) 1997-08-18
NO971898L (no) 1997-06-24
NO20031901D0 (no) 2003-04-28
CN1161652A (zh) 1997-10-08
CA2200967C (en) 2007-09-25
NO323078B1 (no) 2006-12-27
FI970995A (fi) 1997-04-25
PL184368B1 (pl) 2002-10-31
KR20040074104A (ko) 2004-08-21
ATE411800T1 (de) 2008-11-15
MY129435A (en) 2007-04-30
DE69535869D1 (de) 2008-12-04
JP2004359696A (ja) 2004-12-24
CA2200967A1 (en) 1996-05-09
FI970995A0 (fi) 1997-03-10
KR100541198B1 (ko) 2007-04-11
NO20031901L (no) 1997-06-24
IL129547A0 (en) 2000-02-29
TR199501321A2 (tr) 1996-06-21
CN1124157C (zh) 2003-10-15
TW308544B (de) 1997-06-21
KR970706837A (ko) 1997-12-01
ES2316150T3 (es) 2009-04-01
IL115742A0 (en) 1996-01-19
TR199500299A2 (tr) 1997-06-23
NZ295655A (en) 1998-12-23
PE52896A1 (es) 1996-12-12
IL129547A (en) 2001-01-11
IL115742A (en) 2000-06-01
FI119497B (fi) 2008-12-15
PT787011E (pt) 2009-01-23
KR100518135B1 (ko) 2005-10-04

Similar Documents

Publication Publication Date Title
SK286178B6 (sk) Farmaceutická kompozícia obsahujúca makrolid a kyselinu, spôsob stabilizácie makrolidu proti degradácii a použitie kyseliny na jeho stabilizáciu
US6565859B1 (en) Galenical formulations
KR100443306B1 (ko) 사이클로스포린 또는 마크롤라이드를 포함하는 에멀젼예비농축물
US20060058399A1 (en) Emulsion preconcentrates containing cyclosporin or a macrolide
US20070208075A1 (en) Pharmaceutical compositions
KR100678829B1 (ko) 타크로리무스의 경구용 마이크로에멀젼 조성물
GB2278780A (en) Macrolide antibiotic emulsions
RU2292887C2 (ru) Фармацевтический состав, применение карбоновой кислоты для стабилизации макролида в этом составе и способ стабилизации макролида
RU2181054C2 (ru) Микроэмульсионный предконцентрат
RU2235554C2 (ru) Предварительно приготовленные эмульсионные концентраты, содержащие циклоспорин или макролид
MXPA97002701A (en) Microemulsion preconcentrates that contain cyclosporine or a macról
CA2513441A1 (en) Pharmaceutical compositions
PL184711B1 (pl) Prekoncentrat mikroemulsji
MXPA00008735A (en) Emulsion preconcentrates containing cyclosporin or a macrolide

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20091025